Denosumab (XGEVA) et risque d’ostéonécrose de la mâchoire - Lettre aux professionnels de santé (23/07/2015)

Powered by eZ Publish™ CMS Open Source Web Content Management. Copyright © 1999-2014 eZ Systems AS (except where otherwise noted). All rights reserved.